Treatment patterns of oral corticosteroid and nonsteroidal immunosuppressant therapy and clinical outcomes in US patients receiving ravulizumab or eculizumab for generalized myasthenia gravis

Publication Date

2026

Content Type

Article

PubMed ID:

42880190

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS